Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2025 20:29 ET | Source: Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Altimmune, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability of its IMPACT Phase 2b MASH Trial